The limitations of persistence as a measure of efficacy of biologic therapies
Br J Dermatol
.
2023 Nov 16;189(6):e100-e101.
doi: 10.1093/bjd/ljad322.
Author
Robert S Stern
1
Affiliation
1
Department of Dermatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
PMID:
37671667
DOI:
10.1093/bjd/ljad322
No abstract available
Publication types
Editorial
Comment
MeSH terms
Biological Factors
Biological Products* / therapeutic use
Biological Therapy
Cohort Studies
Humans
Insurance, Health
Psoriasis* / drug therapy
Substances
Biological Factors
Biological Products